Liraglutide (Saxenda) earned FDA approval in 2014 to treat weight loss, but GLP-1s as a class took off with the 2021 approval of semaglutide (Wegovy) for chronic weight management
Here is a list of some of the injuries listed in Ozempic lawsuits and scientific studies that researched those injuries in people who take GLP-1 drugs: Ileus: Intestinal blockages were 3.5 times more likely in patients taking Ozempic or another GLP-1RA, according to one study
Noom may include features such as food logging, activity tracking, educational content, and optional coaching support depending on the selected program
Insurance coverage: some insurance plans cover Ozempic or Mounjaro if you have type 2 diabetes
Fourth, an important issue that is often raised is whether any GLP-1RAs can indeed penetrate the bloodbrain barrier and therefore express any neurobiological activity in the CNS, which would result in cognitive or behavioral changes